Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:07 am Purchase |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
RTW Investments, LP | 1,726,808 5.600% |
1,726,808 (New Position) |
Filing History |
| 2024-02-14 07:06 am Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
RTW Investments, LP | 3,592,759 6.400% |
3,592,759 (New Position) |
Filing History |
| 2024-02-14 07:06 am Purchase |
2023-12-31 | 13G | Arvinas, Inc. ARVN |
RTW Investments, LP | 4,213,483 6.200% |
4,213,483 (New Position) |
Filing History |
| 2024-02-14 07:05 am Purchase |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 2,298,662 5.200% |
2,298,662 (New Position) |
Filing History |
| 2024-02-14 07:04 am Purchase |
2023-12-31 | 13G | GH Research PLC GHRS |
RTW Investments, LP | 3,327,129 6.400% |
3,327,129 (New Position) |
Filing History |
| 2024-02-14 07:03 am Purchase |
2023-12-31 | 13G | Pharming Group N.V. PHAR |
RTW Investments, LP | 38,496,391 5.800% |
38,496,391 (New Position) |
Filing History |
| 2024-02-14 07:02 am Purchase |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
RTW Investments, LP | 2,232,760 6.200% |
2,232,760 (New Position) |
Filing History |
| 2024-02-14 07:02 am Purchase |
2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
RTW Investments, LP | 9,220,672 9.990% |
9,220,672 (New Position) |
Filing History |
| 2024-01-24 08:13 am Purchase |
2024-01-24 | 13D | Avidity Biosciences, Inc. RNA |
RTW Investments, LP | 6,701,489 8.400% |
744,931 (+12.51%) |
Filing History |
| 2024-01-18 9:20 pm Sale |
2024-01-18 | 13G | CUTERA INC CUTRQ |
RTW Investments, LP | 1,817,585 9.110% |
-29,011 (-1.57%) |
Filing History |
| 2023-12-12 4:19 pm Sale |
2023-12-08 | 13D | DermTech, Inc. DMTKQ |
RTW Investments, LP | 0 0.000% |
-3,018,666 (Position Closed) |
Filing History |
| 2023-11-24 4:15 pm Purchase |
2023-11-14 | 13G | Lyra Therapeutics, Inc. LYRA |
RTW Investments, LP | 5,175,832 13.400% |
5,175,832 (New Position) |
Filing History |
| 2023-09-19 4:15 pm Unchanged |
2023-09-15 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 18,188,457 20.320% |
0 (Unchanged) |
Filing History |
| 2023-08-11 4:15 pm Purchase |
2023-08-01 | 13D | Allurion Technologies Inc. ALUR |
RTW Investments, LP | 138,308 7.400% |
138,308 (New Position) |
Filing History |
| 2023-05-10 2:24 pm Unchanged |
2023-05-09 | 13D | CUTERA INC CUTRQ |
RTW Investments, LP | 1,846,596 9.300% |
0 (Unchanged) |
Filing History |
| 2023-05-05 09:14 am Purchase |
2023-04-13 | 13D | Orchestra BioMed Holdings, Inc. OBIO |
RTW Investments, LP | 5,620,645 15.700% |
502,133 (+9.81%) |
Filing History |
| 2023-04-12 9:29 pm Purchase |
2023-04-12 | 13D | CUTERA INC CUTRQ |
RTW Investments, LP | 1,846,596 9.300% |
47,921 (+2.66%) |
Filing History |
| 2023-04-05 4:31 pm Sale |
2022-12-01 | 13D | Renovacor, Inc. RCOR |
RTW Investments, LP | 0 0.000% |
-3,350,803 (Position Closed) |
Filing History |
| 2023-04-05 4:31 pm Purchase |
2022-12-01 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 18,188,457 23.000% |
559,890 (+3.18%) |
Filing History |
| 2023-02-14 10:29 am Sale |
2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
RTW Investments, LP | 0 0.000% |
-3,806,018 (Position Closed) |
Filing History |